Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 02, 2026
Why a second opinion can be a good first choice
Lifelong researcher chose proton therapy to treat his prostate cancer
Dr. Andrew Hsieh named Larry and Virginia Gordon Endowed Chair in Prostate and Bladder Cancer Research
A new endowed chair created by Larry and Virginia Gordon helps accelerate discoveries for bladder and prostate cancer
Dr. Heather Cheng receives the Marty Lazarus Weiden Family Endowed Chair
Funding will support innovative work to detect, prevent and treat hereditary cancers
Speed dating? Shark Tank? Trainees promote their ideas for incorporating AI into their science
AI is enhancing research and care at Fred Hutch
Better mitochondrial function may prevent muscle wasting in prostate cancer patients
From Dr. Jose M. Garcia, MD, PhD, UW Medicine
TEAD1 splicing controls prostate cancer identity
From Drs. Michael Haffner and Colm Morrissey, Cancer Consortium
Beyond the 5-year myth: How survivorship care helps cancer patients live well
In this episode of From Bench to Bedside and Beyond, we discuss why Survivorship programs exist and how Fred Hutch’s program is changing to better serve patients
ASCO Young Investigator Award winners showcase the breadth and depth of Fred Hutch research
Hematology-oncology fellows and faculty receive $50,000 each toward early-career projects
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards
Three-year projects explore epigenetics to make new therapies or make existing therapies work better
The Beam: Lymphoma treatment considerations for young patients; when to screen for prostate cancer; meet a spiritual health provider
Dr. Yolanda Tseng discusses the treatment nuances of certain lymphomas; prostate cancer screening info; meet Kyle Turver
Assessing HER2 expression in metastatic prostate and urothelial cancers
From Dr. Raychaudhuri, Dr. Haffner and colleagues, Clinical Research Division
Colorado patient chooses proton therapy following prostate cancer surgery
With no local proton therapy facilities, patient turned to Fred Hutch for its research and reputation
Probing the predictive power of precision diagnostics
From the Etzioni Group, Public Health Sciences Division and the Cancer Consortium
Más allá de las cifras: la confianza, la voz y la lucha contra el cáncer de próstata
Del grupo de investigación Nyame, Departamento de Ciencias de la Salud Pública.
Lived experience matters: patient engagement improves cancer care, research
Nearly 15 years in, Fred Hutch Patient and Family Engagement Program continues to inform care, expands to match advocates with researchers